UTHRUnited Therapeutics Corp.

United Therapeutics Corp. is a biotechnology company focused on developing and commercializing medicines for patients with serious, chronic, and life-threatening diseases. Its portfolio centers on therapies for pulmonary arterial hypertension, including inhaled, oral, and injectable treatments built around treprostinil, as well as additional products for selected rare and severe conditions. The company also markets delivery systems and related treatment options that support ongoing care in specialized respiratory and cardiovascular settings. United Therapeutics Corp. serves patients, clinicians, and healthcare providers across the United States and international markets, with a business model centered on specialty pharmaceuticals and disease-specific therapies. Headquartered in Silver Spring, Maryland, United Therapeutics Corp. operates as a biotechnology company with a strong focus on addressing complex unmet medical needs through commercial products and targeted treatment platforms.